NCT05592106View on ClinicalTrials.gov

Gd-EOB-DTPA-enhanced T1 Map for Predicting Postoperative Liver Failure

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 10, 2021

Primary Completion Date

December 20, 2021

Study Completion Date

October 13, 2022

Conditions
Liver Failure
Interventions
DIAGNOSTIC_TEST

T1 mapping on gadoxetic acid-enhanced MRI

All subjects underwent 1.5T Gd-EOB-DTPA-enhanced MRI including pre-contrast and hepatobiliary-phase T1 mapping.

Trial Locations (1)

200032

Zhongshan Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER

NCT05592106 - Gd-EOB-DTPA-enhanced T1 Map for Predicting Postoperative Liver Failure | Biotech Hunter | Biotech Hunter